香港大學

創新技術

Next-generation Cancer Immunotherapy: A Platform Based on ?d-T Cell-derived Exosomes

(內容請參閱英文版)

The research team developed a groundbreaking platform that harnesses the power of an unique immune cell population (γδ-T cell) to create tiny natural particles called exosomes, designed to fight cancer. This technology has already sparked new treatments for multiple tough cancers such as lymphoma, nasopharyngeal carcinoma, lung cancer, liver cancer, gastric cancer and skin cancer. Even more exciting, it could lead to cancer vaccines that not only treat but also prevent cancer before it starts — offering a powerful, new way to save lives and transform healthcare.

Principal Investigator(s)

Team of Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine:

 

Prof. Wenwei TU
Professor

 

Dr. Xiwei WANG
Research Assistant Professor

 

Dr. Yinpin LU
Research Officer


Email: wwtu@hku.hk

Learn More About This Technology Offering: